Market Tracker

07/27 7:21am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.2165
Delayed Data
As of Jul 26
 +0.0054 / +2.56%
Today’s Change
0.20
Today|||52-Week Range
0.64
-39.07%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.21
Today’s open0.22
Day’s range0.21 - 0.22
Volume546,057
Average volume (3 months)326,888
Market cap$19.7M
Dividend yield--
Data as of 07/26/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-76.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.88

Competitors

 Today’s
change
Today’s
% change
FSIFlexible Solutions I...+0.07+4.00%
HTGMHTG Molecular Diagno...-0.04-1.63%
ABACAoxin Tianli Group I...-0.06-6.99%
BASIBioanalytical System...+0.23+19.54%
Data as of 07/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts